Literature DB >> 23549929

Community-acquired pneumonia: symptoms and burden of illness at diagnosis among US adults aged 50 years and older.

Kathleen W Wyrwich1, Holly Yu, Reiko Sato, David Strutton, John H Powers.   

Abstract

PURPOSE: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality in older adults, yet few studies have comprehensively measured the burden of CAP symptoms and their impact from the patient perspective. Our Web-survey used the newly developed CAP burden of illness questionnaire (CAP-BIQ) designed to assess the presence of key symptoms, comorbid conditions affected by CAP, psychosocial impacts, productivity, and CAP-associated physician visits in US adults aged 50 years and older.
METHODS: The CAP-BIQ was developed from semi-structured one-on-one interviews and finalized after cognitive debriefings with recently diagnosed CAP patients. The CAP-BIQ was then administered to 500 survey participants with a CAP diagnosis within the past 120 days confirmed by chest imaging recruited from a Web-based panel. Analyses of survey results were weighted for national representativeness, and were compared between relevant age, hospitalization status, and pneumonia-risk subgroups.
RESULTS: The survey participants' mean age was 62.4 years; 45 % were men; and 39.6 % were hospitalized due to CAP. On average, the surveys were completed 56.9 days after pneumonia diagnosis. Nearly all participants reported tiredness, cough, body aches, weakness, shortness of breath, wheezing, and a weak appetite at the time of diagnosis (99.0, 96.8, 96.9, 94.1, 89.1, 85.8, and 78.5 %, respectively). There was generally greater symptom prevalence at diagnosis in younger, nonhospitalized, or high-risk subgroups when compared to their respective older, hospitalized, or low-risk counterparts. Most participants reported at least one cough-related and weakness-related impact on their daily life and activities from CAP. Over three quarters of the respondents (77.4 %) needed assistance from a friend or family member during their bout with pneumonia and a majority of respondents (83.6 %) were satisfied with the care they received from their doctors across the course of their illness.
CONCLUSIONS: This study systematically assessed CAP symptoms and their impacts using the CAP-BIQ, a questionnaire with established content validity. At CAP diagnosis, the range of patient-reported symptoms was broader than previous studies have reported. Additionally, the overwhelming need for caregiver assistance demonstrates the burden this illness places on older adults.

Entities:  

Mesh:

Year:  2013        PMID: 23549929     DOI: 10.1007/s40271-013-0013-4

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  24 in total

1.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-10       Impact factor: 5.725

2.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-13       Impact factor: 5.725

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

4.  Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-09-03       Impact factor: 17.586

5.  Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.

Authors:  Drahomir Aujesky; Thomas E Auble; Donald M Yealy; Roslyn A Stone; D Scott Obrosky; Thomas P Meehan; Louis G Graff; Jonathan M Fine; Michael J Fine
Journal:  Am J Med       Date:  2005-04       Impact factor: 4.965

6.  The relationship between age and fever magnitude.

Authors:  M C Roghmann; J Warner; P A Mackowiak
Journal:  Am J Med Sci       Date:  2001-08       Impact factor: 2.378

7.  Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study.

Authors:  M J Fine; R A Stone; D E Singer; C M Coley; T J Marrie; J R Lave; L J Hough; D S Obrosky; R Schulz; E M Ricci; J C Rogers; W N Kapoor
Journal:  Arch Intern Med       Date:  1999-05-10

8.  Community-acquired pneumonia requiring hospitalization. Is it different in the elderly?

Authors:  T J Marrie; E V Haldane; R S Faulkner; H Durant; C Kwan
Journal:  J Am Geriatr Soc       Date:  1985-10       Impact factor: 5.562

9.  Time course of symptom resolution in patients with community-acquired pneumonia.

Authors:  J P Metlay; S J Atlas; L H Borowsky; D E Singer
Journal:  Respir Med       Date:  1998-09       Impact factor: 3.415

Review 10.  Pneumonia in older persons.

Authors:  Mark Loeb
Journal:  Clin Infect Dis       Date:  2003-10-13       Impact factor: 9.079

View more
  12 in total

1.  Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health.

Authors:  George H Talbot; John H Powers; Steven C Hoffmann
Journal:  Clin Infect Dis       Date:  2015-12-13       Impact factor: 9.079

2.  Pneumococcal Vaccination Among Adults With Work-related Asthma.

Authors:  Katelynn E Dodd; Jacek M Mazurek
Journal:  Am J Prev Med       Date:  2017-09-27       Impact factor: 5.043

3.  Changes in the epidemiology and burden of community-acquired pneumonia in Korea.

Authors:  Hyoung Kyu Yoon
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

4.  Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis.

Authors:  Kimberly C Claeys; Evan J Zasowski; Trang D Trinh; Abdalhamid M Lagnf; Susan L Davis; Michael J Rybak
Journal:  Infect Dis Ther       Date:  2017-11-21

5.  Patient-reported outcome measures in community-acquired pneumonia: a systematic review of application and content validity.

Authors:  Melanie Lloyd; Emily Callander; Amalia Karahalios; Lucy Desmond; Harin Karunajeewa
Journal:  BMJ Open Respir Res       Date:  2019-06-02

6.  Differences between diabetic and non-diabetic patients with community-acquired pneumonia in primary care in Spain.

Authors:  Loreto Arias Fernández; Jacobo Pardo Seco; Miriam Cebey-López; Ruth Gil Prieto; Irene Rivero-Calle; Federico Martinon-Torres; Ángel Gil de Miguel; F Martinón-Torres; D Vargas; E Mascarós; E Redondo; J L Díaz-Maroto; M Linares-Rufo; A Gil; J Molina; D Ocaña; I Rivero-Calle
Journal:  BMC Infect Dis       Date:  2019-11-15       Impact factor: 3.090

7.  Symptomatic, biochemical and radiographic recovery in patients with COVID-19.

Authors:  Patrick Mallia; Onn Min Kon; Jamilah Meghji; Brandon Wong; Kartik Kumar; Victoria Pilkington; Shaan Chhabra; Ben Russell; Jian Chen; Karthikan Srikanthan; Mirae Park; Harriet Owles; Felicity Liew; Joana Alcada; Laura Martin; Meg Coleman; Sarah Elkin; Clare Ross; Shweta Agrawal; Thomas Gardiner; Aaron Bell; Alice White; Dominic Hampson; Gauri Vithlani; Kavina Manalan; Solange Bramer; Alejandra Martin Segura; Anushree Kucheria; Prashanthi Ratnakumar; Alexander Sheeka; Lavanya Anandan; Susan Copley; Georgina Russell; Chloe I Bloom
Journal:  BMJ Open Respir Res       Date:  2021-04

8.  Observational longitudinal study of symptom burden and time for recovery from community-acquired pneumonia reported by older adults surveyed nationwide using the CAP Burden of Illness Questionnaire.

Authors:  Kathleen W Wyrwich; Holly Yu; Reiko Sato; John H Powers
Journal:  Patient Relat Outcome Meas       Date:  2015-07-30

Review 9.  Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.

Authors:  Antoni Torres; Francesco Blasi; Nathalie Dartois; Murat Akova
Journal:  Thorax       Date:  2015-07-28       Impact factor: 9.139

10.  Patient-reported outcome measurement in community-acquired pneumonia: feasibility of routine application in an elderly hospitalized population.

Authors:  Melanie A Lloyd; Clarice Y Tang; Emily J Callander; Edward D Janus; Amalia Karahalios; Elizabeth H Skinner; Stephanie Lowe; Harin A Karunajeewa
Journal:  Pilot Feasibility Stud       Date:  2019-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.